awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33414307-4AD88CA6-ADF7-4208-87F2-357148C703A1
Q33414307-4AD88CA6-ADF7-4208-87F2-357148C703A1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33414307-4AD88CA6-ADF7-4208-87F2-357148C703A1
A phase I/II study of the pan Bcl-2 inhibitor obatoclax mesylate plus bortezomib for relapsed or refractory mantle cell lymphoma.
P2860
Q33414307-4AD88CA6-ADF7-4208-87F2-357148C703A1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33414307-4AD88CA6-ADF7-4208-87F2-357148C703A1
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
191c9c8eea5801fffb53bfe31ecddb567ce06d2f
P2860
A phase I study of the pan bcl-2 family inhibitor obatoclax mesylate in patients with advanced hematologic malignancies.